These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 816805

  • 1. Absence of nocturnal elevation of plasma prolactin concentrations in Cushing's disease.
    Krieger DT, Howanitz PJ, Frantz AG.
    J Clin Endocrinol Metab; 1976 Feb; 42(2):260-72. PubMed ID: 816805
    [Abstract] [Full Text] [Related]

  • 2. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT, Luria M.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [Abstract] [Full Text] [Related]

  • 3. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP, Molinie P, Strauch G, Guilhaume B, Bricaire H.
    Sem Hop; 1977 Feb; 57(17-18):841-9. PubMed ID: 6262921
    [Abstract] [Full Text] [Related]

  • 4. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiology of Cushing's disease.
    Fehm HL, Voigt KH.
    Pathobiol Annu; 1979 Apr; 9():225-55. PubMed ID: 225710
    [Abstract] [Full Text] [Related]

  • 6. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT, Allen W.
    J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
    [Abstract] [Full Text] [Related]

  • 7. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis.
    Mukherjee A, Murray RD, Columb B, Gleeson HK, Shalet SM.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):743-8. PubMed ID: 14974916
    [Abstract] [Full Text] [Related]

  • 8. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF, Smals AG, Goverde HJ, Pesman GJ, Meyer E, Kloppenborg PW.
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [Abstract] [Full Text] [Related]

  • 9. Thyrotrophin and prolactin responsiveness to thyrotrophin releasing hormone in Cushing's disease.
    Kuku SF, Child DF, Nader S, Fraser TR.
    Clin Endocrinol (Oxf); 1975 Jul; 4(4):437-42. PubMed ID: 807441
    [Abstract] [Full Text] [Related]

  • 10. A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease.
    Allolio B, Günther RW, Benker G, Reinwein D, Winkelmann W, Schulte HM.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1195-201. PubMed ID: 1699962
    [Abstract] [Full Text] [Related]

  • 11. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T, Ishibashi M, Teramoto A, Fukushima T.
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [Abstract] [Full Text] [Related]

  • 12. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 13. Evidence for two subtypes of Cushing's disease based on the analysis of episodic cortisol secretion.
    Van Cauter E, Refetoff S.
    N Engl J Med; 1985 May 23; 312(21):1343-9. PubMed ID: 3873008
    [Abstract] [Full Text] [Related]

  • 14. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF, Hermus AR, Smals AG, Bartelink AK, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1983 Sep 23; 57(3):513-6. PubMed ID: 6308029
    [Abstract] [Full Text] [Related]

  • 15. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B, Winkelmann W, Hipp FX, Kaulen D, Mies R.
    J Clin Endocrinol Metab; 1982 Jul 23; 55(1):1-7. PubMed ID: 6281297
    [Abstract] [Full Text] [Related]

  • 16. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG, Frölich M, Pincus SM, Veldhuis JD, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Nov 23; 85(11):4039-46. PubMed ID: 11095430
    [Abstract] [Full Text] [Related]

  • 17. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B, Deuss U, Kaulen D, Leonhardt U, Kallabis D, Hamel E, Winkelmann W.
    J Clin Endocrinol Metab; 1986 Dec 23; 63(6):1427-31. PubMed ID: 3023423
    [Abstract] [Full Text] [Related]

  • 18. The nocturnal serum thyrotropin surge is abolished in patients with adrenocorticotropin (ACTH)-dependent or ACTH-independent Cushing's syndrome.
    Bartalena L, Martino E, Petrini L, Velluzzi F, Loviselli A, Grasso L, Mammoli C, Pinchera A.
    J Clin Endocrinol Metab; 1991 Jun 23; 72(6):1195-9. PubMed ID: 1851180
    [Abstract] [Full Text] [Related]

  • 19. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May 23; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Feb 23; 72(2):260-71. PubMed ID: 1846869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.